Concern Over Biosimilar-To-Biosimilar Switch Could Impact Approval, US FDA Official Says

 
• By Derrick Gingery
  
biosimilar switching concept
An upcoming FDA workshop could help streamline biosimilar development. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics